Let’s start up with the current stock price of ImmunityBio Inc. (IBRX), which is $2.68 to be very precise. The Stock rose vividly during the last session to $3.45 after opening rate of $3.45 while the lowest price it went was recorded $2.62 before closing at $3.45.Recently in News on April 28, 2022, ImmunityBio To Present Data From Multiple Clinical Trials at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Data from ImmunityBio’s QUILT 3.032 BCG-unresponsive non-muscle invasive bladder cancer trial will be presented by principal investigator in an oral presentation. You can read further details here
ImmunityBio Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.85 on 02/17/22, with the lowest value was $2.62 for the same time period, recorded on 05/11/22.
ImmunityBio Inc. (IBRX) full year performance was -82.36%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ImmunityBio Inc. shares are logging -85.23% during the 52-week period from high price, and -12.13% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.05 and $18.14.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4261593 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ImmunityBio Inc. (IBRX) recorded performance in the market was -55.92%, having the revenues showcasing -57.80% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.14B, as it employees total of 587 workers.
The Analysts eye on ImmunityBio Inc. (IBRX)
During the last month, 0 analysts gave the ImmunityBio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 5.71, with a change in the price was noted -2.99. In a similar fashion, ImmunityBio Inc. posted a movement of -52.73% for the period of last 100 days, recording 1,655,684 in trading volumes.
Technical rundown of ImmunityBio Inc. (IBRX)
Raw Stochastic average of ImmunityBio Inc. in the period of last 50 days is set at 1.43%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 2.21%. In the last 20 days, the company’s Stochastic %K was 6.75% and its Stochastic %D was recorded 9.16%.
Considering, the past performance of ImmunityBio Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -55.92%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -66.91%, alongside a downfall of -82.36% for the period of the last 12 months. The shares increased approximately by -39.09% in the 7-day charts and went up by -45.64% in the period of the last 30 days. Common stock shares were lifted by -57.80% during last recorded quarter.